Clinical Trial: Aβ1-40 as a "Molecular Bridge" Bidirectionally Regulates Macrophage Foam Cell Formation via RAGE to Promote Atherosclerosis: An Observational Study of Protein Analysis in Atherosclerotic Plaque Tissue and Plasma Samples from Patients Undergoing Carotid Endarterectomy (China)

China, Oct. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Aβ1-40 as a "Molecular Bridge" Bidirectionally Regulates Macrophage Foam Cell Formation via RAGE to Promote Atherosclerosis: An Observational Study of Protein Analysis in Atherosclerotic Plaque Tissue and Plasma Samples from Patients Undergoing Carotid Endarterectomy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133719

Registration Time: 2026/09/30

Type: Observational study

Primary Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346085

Published by HT Digit...